Company Profile
live
MediumAlchemab Therapeutics Ltd
12156844•Private Limited With Share Capital
East Side Office 1.02, Kings Cross, London, N1C4AX
Get Full Access
Incorporated
14/08/2019
Company Age
7 years
Directors
7
Employees
60
SIC Code
72110
Risk
moderate risk
Company Overview
Registration, classification & business activity
Alchemab Therapeutics Ltd (12156844) is a private limited with share capital incorporated on 14/08/2019 (7 years old) and registered in london, N1C4AX. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. alchemab takes an unbiased and function-first approach using three complementary processes and cutting-e...
Private Limited With Share Capital
SIC: 72110
Medium
Incorporated 14/08/2019
N1C4AX
60 employees
Financial Overview
Total Assets
£22.43M
Liabilities
£31.77M
Net Assets
£-9.34M
Turnover
£1.59M
Cash
£15.58M
Key Metrics
60
Employees
7
Directors
53
Shareholders
25
Patents
Board of Directors
5
Name
Position
director
director
director
director
director
Charges
1
Registered
0
Outstanding
0
Part Satisfied
1
Satisfied
Filed Documents
91
Document Name
Category
Date
Capital Allotment Shares
Category:Capital
Date:14-07-2026
Capital Allotment Shares
Category:Capital
Date:14-07-2026
Memorandum Articles
Category:Incorporation
Date:07-07-2026
Resolution
Category:Resolution
Date:07-07-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:01-07-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:23-06-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:19-06-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:19-06-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:19-06-2026
Change Person Secretary Company With Change Date
Category:Officers
Date:10-03-2026
Appoint Person Secretary Company With Name Date
Category:Officers
Date:10-03-2026
Confirmation Statement With Updates
Category:Confirmation Statement
Date:12-12-2025
Capital Allotment Shares
Category:Capital
Date:20-11-2025
Capital Allotment Shares
Category:Capital
Date:22-10-2025
Accounts With Accounts Type Medium
Category:Accounts
Date:02-10-2025
Capital Allotment Shares
Category:Capital
Date:28-08-2025
Capital Allotment Shares
Category:Capital
Date:31-07-2025
Capital Name Of Class Of Shares
Category:Capital
Date:28-07-2025
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:28-07-2025
Resolution
Category:Resolution
Date:16-07-2025
Memorandum Articles
Category:Incorporation
Date:16-07-2025
Capital Allotment Shares
Category:Capital
Date:29-04-2025
Capital Allotment Shares
Category:Capital
Date:10-01-2025
Accounts With Accounts Type Group
Category:Accounts
Date:03-01-2025
Capital Allotment Shares
Category:Capital
Date:11-12-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:29-11-2024
Capital Allotment Shares
Category:Capital
Date:27-11-2024
Capital Allotment Shares
Category:Capital
Date:18-10-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:16-09-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:12-09-2024
Resolution
Category:Resolution
Date:28-08-2024
Capital Allotment Shares
Category:Capital
Date:02-08-2024
Capital Allotment Shares
Category:Capital
Date:02-07-2024
Resolution
Category:Resolution
Date:15-05-2024
Resolution
Category:Resolution
Date:15-05-2024
Capital Allotment Shares
Category:Capital
Date:18-04-2024
Capital Allotment Shares
Category:Capital
Date:23-01-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:01-12-2023
Capital Allotment Shares
Category:Capital
Date:17-10-2023
Capital Allotment Shares
Category:Capital
Date:11-08-2023
Accounts With Accounts Type Group
Category:Accounts
Date:08-08-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:01-08-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:01-08-2023
Capital Allotment Shares
Category:Capital
Date:25-04-2023
Capital Allotment Shares
Category:Capital
Date:27-02-2023
Capital Allotment Shares
Category:Capital
Date:10-01-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:08-12-2022
Capital Allotment Shares
Category:Capital
Date:03-11-2022
Capital Allotment Shares
Category:Capital
Date:30-08-2022
Capital Allotment Shares
Category:Capital
Date:30-08-2022
Accounts With Accounts Type Group
Category:Accounts
Date:15-07-2022
Second Filing Capital Allotment Shares
Category:Capital
Date:11-07-2022
Capital Allotment Shares
Category:Capital
Date:11-07-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:01-06-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:01-06-2022
Mortgage Satisfy Charge Full
Category:Mortgage
Date:16-03-2022
Resolution
Category:Resolution
Date:17-02-2022
Capital Allotment Shares
Category:Capital
Date:16-02-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-01-2022
Capital Allotment Shares
Category:Capital
Date:17-01-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:19-10-2021
Accounts With Accounts Type Small
Category:Accounts
Date:23-07-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:06-07-2021
Mortgage Create With Deed With Charge Number Charge Creation Date
Category:Mortgage
Date:27-05-2021
Capital Allotment Shares
Category:Capital
Date:11-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:10-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:10-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:10-05-2021
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:10-05-2021
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:10-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:07-05-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:07-05-2021
Termination Director Company With Name Termination Date
Category:Officers
Date:07-05-2021
Memorandum Articles
Category:Incorporation
Date:05-05-2021
Resolution
Category:Resolution
Date:05-05-2021
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:30-03-2021
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:30-03-2021
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:29-03-2021
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:25-02-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-02-2021
Capital Allotment Shares
Category:Capital
Date:30-06-2020
Termination Director Company With Name Termination Date
Category:Officers
Date:30-06-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:30-06-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-11-2019
Capital Alter Shares Subdivision
Category:Capital
Date:04-11-2019
Capital Allotment Shares
Category:Capital
Date:04-11-2019
Resolution
Category:Resolution
Date:04-11-2019
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:09-09-2019
Change Person Director Company With Change Date
Category:Officers
Date:09-09-2019
Change Account Reference Date Company Current Extended
Category:Accounts
Date:09-09-2019
Incorporation Company
Category:Incorporation
Date:14-08-2019
Innovate Grants
2
This company received a grant of £988266.0 for Novel Protective 'Self'-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/03/2021 and ended on 31/10/2022.
This company received a grant of £1350188.0 for Pre-Clinical Development Of Novel ‘Self’-Antibodies For Disease Modification In Huntington’S Disease. The project started on 01/12/2022 and ended on 28/02/2025.
Import / Export
Imports
12 Months9
60 Months49
Exports
12 Months7
60 Months25
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typemedium company
Due Date30/09/2026
Filing Date26/09/2025
Latest Accounts31/12/2024
Trading Addresses
East Side, Kings Cross Station, Kings Cross, London, N1C4AXRegistered
Related Companies
10